Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Risk-Free Satisfaction: We stand behind our product's effectiveness and your satisfaction
Glia 63 , 5165
Akkermansia muciniphila : a potential candidate for ameliorating metabolic diseases
In an announcement of the study on the Vanderbilt website, lead author Khrysta Baig described this as a purely hypothetical scenario, but one that underscores that at current prices, these medications cannot be the only way or even the main way we address obesity as a society. In a more conservative estimate, Bhaig and coauthors consider a case where only about 10% of those eligible for obesity treatment opted for semaglutide, which would result in $27 billion in new costs
J Nutr Biochem
Moreover, variability in study populations and healthcare settings limits the direct comparability of results and may influence the magnitude of observed treatment effects
